Executives at Amgen made the case for MariTide's differentiation, while Merck's CEO contended Keytruda's coming loss of exclusivity can be managed.

BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its ...

The two types of immunotherapies used for kidney cancer are: Checkpoint inhibitors: These medicines work by targeting checkpoint proteins, which helps the immune system fight cancer cells. Some ...

For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with the ...

Kidney stones are pebble-sized deposits that form when there’s too much salt and minerals in your urine. Learn whether men or women are more at risk, what passing one feels like, and how big ...

Management of advanced renal cell carcinoma remains a persistent clinical challenge with high morbidity and mortality for a large proportion of patients. Until recently, available medical ...

(n = 65) Randomized, discontinuation trial (part 2 of a two-part trial) Sorafenib Placebo Rate of progression-free survival 12 wk after randomization: 50% (sorafenib) vs. 18% (placebo) (p = 0.0077 ...

Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a leading ...

9 In 2023, Aggarwal et al. published the results of a phase 1 trial of single dose 177 Lu-PSMA-617 followed by maintenance pembrolizumab in mCRPC patients. From an efficacy standpoint, 44% of patients ...

The consumption of energy drinks can contribute to the formation of kidney stones—as can many other foods and beverages. What makes energy drinks distinct is that they contain an especially high ...

“In this phase 2 study, an image-guided adaptive strategy enabled radiotherapy dose escalation to over 86% of patients’ bladder tumors without significant increase in toxicity,” wrote the authors.